Authored by Richard Jefferys and Suraj Madoori with input from members of the COVID-19 Working Group-New York and delivered by Lizzy Lovinger, TAG provided public comments at the Vaccines and Related Biological Products Advisory Committee Meeting on Thursday, October 22. TAG’s comments urged the Committee to resist political interference and to uphold stringent regulatory authority in reviewing safety, efficacy, inclusion, and transparency of the vaccine research and approval processes. Video of the meeting is available on YouTube.
Treatment Action Group Comments for the FDA Advisory Committee Meeting on COVID-19 Vaccines